Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Duke University
mi
from
Durham, NC
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve Univ
mi
from
Cleveland, OH
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh-Magee Womens Hospital
mi
from
Pittsburgh, PA
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh-Magee Womens Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Brown University
mi
from
Providence, RI
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated:  12/31/1969
University of Texas - Southwest
mi
from
Dallas, TX
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated: 12/31/1969
University of Texas - Southwest
mi
from
Dallas, TX
Click here to add this to my saved trials
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Univ of Texas Galveston
mi
from
Galveston, TX
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Univ of Texas Galveston
mi
from
Galveston, TX
Click here to add this to my saved trials
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated:  12/31/1969
University of Utah Medical Center
mi
from
Salt Lake City, UT
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated: 12/31/1969
University of Utah Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated:  12/31/1969
The University of Texas, Houston
mi
from
Houston, TX
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status: Enrolling
Updated: 12/31/1969
The University of Texas, Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Absorptive Clearance After Inhaled Osmotics in Cystic Fibrosis
Absorptive Clearance After Inhaled Osmotics in Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Absorptive Clearance After Inhaled Osmotics in Cystic Fibrosis
Absorptive Clearance After Inhaled Osmotics in Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
Status: Enrolling
Updated:  12/31/1969
UNC Hospitals
mi
from
Chapel Hill, NC
Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
Status: Enrolling
Updated: 12/31/1969
UNC Hospitals
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
The Respiratory Protection Effectiveness Clinical Trial
Incidence of Respiratory Illness in Outpatient Healthcare Workers Who Wear Respirators or Medical Masks While Caring for Patients
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado Infectious Disease
mi
from
Aurora, CO
The Respiratory Protection Effectiveness Clinical Trial
Incidence of Respiratory Illness in Outpatient Healthcare Workers Who Wear Respirators or Medical Masks While Caring for Patients
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado Infectious Disease
mi
from
Aurora, CO
Click here to add this to my saved trials
The Respiratory Protection Effectiveness Clinical Trial
Incidence of Respiratory Illness in Outpatient Healthcare Workers Who Wear Respirators or Medical Masks While Caring for Patients
Status: Enrolling
Updated:  12/31/1969
Denver Health Medical Center
mi
from
Denver, CO
The Respiratory Protection Effectiveness Clinical Trial
Incidence of Respiratory Illness in Outpatient Healthcare Workers Who Wear Respirators or Medical Masks While Caring for Patients
Status: Enrolling
Updated: 12/31/1969
Denver Health Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
The Respiratory Protection Effectiveness Clinical Trial
Incidence of Respiratory Illness in Outpatient Healthcare Workers Who Wear Respirators or Medical Masks While Caring for Patients
Status: Enrolling
Updated:  12/31/1969
Denver Veterans Administration Medical Center
mi
from
Denver, CO
The Respiratory Protection Effectiveness Clinical Trial
Incidence of Respiratory Illness in Outpatient Healthcare Workers Who Wear Respirators or Medical Masks While Caring for Patients
Status: Enrolling
Updated: 12/31/1969
Denver Veterans Administration Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
The Respiratory Protection Effectiveness Clinical Trial
Incidence of Respiratory Illness in Outpatient Healthcare Workers Who Wear Respirators or Medical Masks While Caring for Patients
Status: Enrolling
Updated:  12/31/1969
Veterans Affairs Medical Center - Washington, DC
mi
from
Washington,
The Respiratory Protection Effectiveness Clinical Trial
Incidence of Respiratory Illness in Outpatient Healthcare Workers Who Wear Respirators or Medical Masks While Caring for Patients
Status: Enrolling
Updated: 12/31/1969
Veterans Affairs Medical Center - Washington, DC
mi
from
Washington,
Click here to add this to my saved trials
The Respiratory Protection Effectiveness Clinical Trial
Incidence of Respiratory Illness in Outpatient Healthcare Workers Who Wear Respirators or Medical Masks While Caring for Patients
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Health Sytstem
mi
from
Baltimore, MD
The Respiratory Protection Effectiveness Clinical Trial
Incidence of Respiratory Illness in Outpatient Healthcare Workers Who Wear Respirators or Medical Masks While Caring for Patients
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Health Sytstem
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Respiratory Protection Effectiveness Clinical Trial
Incidence of Respiratory Illness in Outpatient Healthcare Workers Who Wear Respirators or Medical Masks While Caring for Patients
Status: Enrolling
Updated:  12/31/1969
Houston VA Medical Center
mi
from
Houston, TX
The Respiratory Protection Effectiveness Clinical Trial
Incidence of Respiratory Illness in Outpatient Healthcare Workers Who Wear Respirators or Medical Masks While Caring for Patients
Status: Enrolling
Updated: 12/31/1969
Houston VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
The Respiratory Protection Effectiveness Clinical Trial
Incidence of Respiratory Illness in Outpatient Healthcare Workers Who Wear Respirators or Medical Masks While Caring for Patients
Status: Enrolling
Updated:  12/31/1969
Va New York Harbor Healthcare System
mi
from
New York, NY
The Respiratory Protection Effectiveness Clinical Trial
Incidence of Respiratory Illness in Outpatient Healthcare Workers Who Wear Respirators or Medical Masks While Caring for Patients
Status: Enrolling
Updated: 12/31/1969
Va New York Harbor Healthcare System
mi
from
New York, NY
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
University Of Alabama At Birmingham Hospital
mi
from
Birmingham, AL
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
University Of Alabama At Birmingham Hospital
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Arizona Pulmonary Specialists, Ltd.
mi
from
Scottsdale, AZ
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Arizona Pulmonary Specialists, Ltd.
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Yale University
mi
from
New Haven, CT
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Central Florida Pulmonary Group, PA
mi
from
Orlando, FL
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Central Florida Pulmonary Group, PA
mi
from
Orlando, FL
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Tampa General Hospital
mi
from
Tampa, FL
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Via Christi Hospitals Wichita, Inc.
mi
from
Wichita, KA
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Via Christi Hospitals Wichita, Inc.
mi
from
Wichita, KA
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of Louisville
mi
from
Louisville, KY
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
St. Luke's Hospital
mi
from
Chesterfield, MO
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
St. Luke's Hospital
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Rutgers Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Rutgers Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Mount Sinai
mi
from
New York, NY
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of Utah - Lung Health Research
mi
from
Salt Lake City, UT
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Utah - Lung Health Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Vermont Lung Center
mi
from
Colchester, VT
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Vermont Lung Center
mi
from
Colchester, VT
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Inova Fairfax Hospital
mi
from
Falls Church, VA
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Inova Fairfax Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin School of Medicine and Public Health
mi
from
Madison, WI
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
A Phase 2, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin School of Medicine and Public Health
mi
from
Madison, WI
Click here to add this to my saved trials
Cross-sectional Characterization of Idiopathic Bronchiectasis
Cross-Sectional Characterization of Idiopathic Bronchiectasis
Status: Enrolling
Updated:  12/31/1969
Stanford Medical Center
mi
from
Stanford, CA
Cross-sectional Characterization of Idiopathic Bronchiectasis
Cross-Sectional Characterization of Idiopathic Bronchiectasis
Status: Enrolling
Updated: 12/31/1969
Stanford Medical Center
mi
from
Stanford, CA
Click here to add this to my saved trials
Cross-sectional Characterization of Idiopathic Bronchiectasis
Cross-Sectional Characterization of Idiopathic Bronchiectasis
Status: Enrolling
Updated:  12/31/1969
National Jewish Health
mi
from
Denver, CO
Cross-sectional Characterization of Idiopathic Bronchiectasis
Cross-Sectional Characterization of Idiopathic Bronchiectasis
Status: Enrolling
Updated: 12/31/1969
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Cross-sectional Characterization of Idiopathic Bronchiectasis
Cross-Sectional Characterization of Idiopathic Bronchiectasis
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Cross-sectional Characterization of Idiopathic Bronchiectasis
Cross-Sectional Characterization of Idiopathic Bronchiectasis
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Cross-sectional Characterization of Idiopathic Bronchiectasis
Cross-Sectional Characterization of Idiopathic Bronchiectasis
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Cross-sectional Characterization of Idiopathic Bronchiectasis
Cross-Sectional Characterization of Idiopathic Bronchiectasis
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Cross-sectional Characterization of Idiopathic Bronchiectasis
Cross-Sectional Characterization of Idiopathic Bronchiectasis
Status: Enrolling
Updated:  12/31/1969
St. Michael's Hospital
mi
from
Toronto,
Cross-sectional Characterization of Idiopathic Bronchiectasis
Cross-Sectional Characterization of Idiopathic Bronchiectasis
Status: Enrolling
Updated: 12/31/1969
St. Michael's Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Cross-sectional Characterization of Idiopathic Bronchiectasis
Cross-Sectional Characterization of Idiopathic Bronchiectasis
Status: Enrolling
Updated:  12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Cross-sectional Characterization of Idiopathic Bronchiectasis
Cross-Sectional Characterization of Idiopathic Bronchiectasis
Status: Enrolling
Updated: 12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV
Implantation of the SAPIEN Transcatheter Heart Valve (THV) in the Pulmonic Position
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV
Implantation of the SAPIEN Transcatheter Heart Valve (THV) in the Pulmonic Position
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV
Implantation of the SAPIEN Transcatheter Heart Valve (THV) in the Pulmonic Position
Status: Enrolling
Updated:  12/31/1969
Miami Children's Hospital
mi
from
Miami, FL
COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV
Implantation of the SAPIEN Transcatheter Heart Valve (THV) in the Pulmonic Position
Status: Enrolling
Updated: 12/31/1969
Miami Children's Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV
Implantation of the SAPIEN Transcatheter Heart Valve (THV) in the Pulmonic Position
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital/ Children's Healthcare of Atlanta (CHOA)
mi
from
Atlanta, GA
COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV
Implantation of the SAPIEN Transcatheter Heart Valve (THV) in the Pulmonic Position
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital/ Children's Healthcare of Atlanta (CHOA)
mi
from
Atlanta, GA
Click here to add this to my saved trials
COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV
Implantation of the SAPIEN Transcatheter Heart Valve (THV) in the Pulmonic Position
Status: Enrolling
Updated:  12/31/1969
Rush Medical Center
mi
from
Chicago, IL
COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV
Implantation of the SAPIEN Transcatheter Heart Valve (THV) in the Pulmonic Position
Status: Enrolling
Updated: 12/31/1969
Rush Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV
Implantation of the SAPIEN Transcatheter Heart Valve (THV) in the Pulmonic Position
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV
Implantation of the SAPIEN Transcatheter Heart Valve (THV) in the Pulmonic Position
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV
Implantation of the SAPIEN Transcatheter Heart Valve (THV) in the Pulmonic Position
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of New York
mi
from
New York, NY
COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV
Implantation of the SAPIEN Transcatheter Heart Valve (THV) in the Pulmonic Position
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of New York
mi
from
New York, NY
Click here to add this to my saved trials